Ypsomed Holding AG

Ypsomed Holding AG
Stock Exchange Frankfurt Stock Exchange
EPS
EUR5.8
Market Cap
EUR1.52 B
Shares Outstanding
12.65 M
Public Float
-
Ypsomed Holding AG
Stock Exchange SIX Swiss Exchange
EPS
CHF6.73
Market Cap
CHF1.72 B
Shares Outstanding
12.65 M
Public Float
3.3 M

Profile

Address
Brunnmattstrasse 6
Burgdorf Bern (Berne) 3401
Switzerland
Employees -
Website http://www.ypsomed.com
Updated 07/08/2019
Ypsomed Holding AG engages in the development and manufacture of injection systems for self-medication of drugs by patients, most notably used to treat diabetes. Its products include DiaExpert, BGMS, OmniPod, YpsoPump & Orbit, Pen needles, Injection systems, and Contract manufacturing. The company operates through the following business segments: Ypsomed Diabetes Care, Ypsomed Delivery Systems.

Financials

View All

Wilhelm Michel
Non-Executive Chairman
Paul R. Fonteyne
Director